Collegium Pharmaceutical (COLL) reported $188 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 29.4$1.68 for the same period compares to $1.62 a year ago.The reported revenue compares to the Zacks Consensus Estimate of$180.38 million, representing a surprise of +4.23%. The company delivered an EPS surprise of +3.7%, with the consensus EPS estimate being $1.62.While investors closely watch year-over-year changes in headline numbers -- revenue and earnin ...